IJERPH, Vol. 17, Pages 1954: The Relationship between Frailty Syndrome and Concerns about an Implantable Cardioverter Defibrillator

IJERPH, Vol. 17, Pages 1954: The Relationship between Frailty Syndrome and Concerns about an Implantable Cardioverter Defibrillator:

IJERPH, Vol. 17, Pages 1954: The Relationship between Frailty Syndrome and Concerns about an Implantable Cardioverter Defibrillator

International Journal of Environmental Research and Public Health doi: 10.3390/ijerph17061954

Authors:
Agnieszka Mlynarska
Rafal Mlynarski
Izabella Uchmanowicz
Czeslaw Marcisz
Krzysztof S. Golba


Frailty syndrome may cause cognitive decline and increased sensitivity to stressors. This can result in an increased incidence of anxiety and depression, and thus, concerns about life with an implantable cardioverter defibrillator (ICD). The aim of the study was to assess the impact of frailty syndrome on the increase in the number of device-related concerns after the implantation of an ICD. Material and methods: The study sample was a group of 103 consecutive patients (85 M; aged 71.6 ± 8.2) with an implanted ICD. The ICD Concerns Questionnaire (ICDC) was used to analyze their concerns about life with an ICD, and the Tilburg Frailty Indicator scale (TFI) was used to diagnose frailty. Results: In the group of patients with an ICD implanted, 73% had recognized frailty (83.3% women, 74.1% men); the average point value was 6.55 ± 2.67. The total ICDC questionnaire score for the patients with an implanted cardioverter defibrillator was 34.06 ± 18.15. Patients with frailty syndrome had statistically (p = 0.039) higher scores (36.14 ± 17.08) compared to robust patients (27.56 ± 20.13). In the logistic regression analysis, the presence of frailty was strongly associated with the total questionnaire score (OR = 1.0265, p = 0.00426), the severity of the concerns (OR = 1.0417, p = 0.00451), and device-specific concerns (OR = 1.0982, p = 0.00424). Conclusion: Frailty syndrome occurs in about 80% of patients after ICD implantation. The presence of frailty syndrome was strongly associated with concerns about an implantable cardioverter defibrillator.